Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tustin, CA
SEC filing record 1 source field available
Fiscal year end
30 April
Avid Bioservices, Inc. has filed 1,388 SEC EDGAR filings since 14 Sep 1995

SEC filing history

Showing 851-875 of 992 matching filings.

Per page
25
Current page
35
SC 13G/A File 005-37393

SC 13G/A filing

Filing date
11 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
21 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
21 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
21 May 2012
Reporting date
21 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
08 May 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 May 2012
Reporting date
30 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 May 2012
Reporting date
30 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 May 2012
Reporting date
30 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 May 2012
Reporting date
30 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-180028

EFFECT filing

Filing date
12 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-180028

PEREGRINE PHARMACEUTICALS, INC.

Filing date
04 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8K

Filing date
28 Mar 2012
Reporting date
28 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-32839

FORM 8-K

Filing date
16 Mar 2012
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
16 Mar 2012
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .